National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

190

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C03CA02	BURINEX	B	Bumetanide - 5mg	5mg	Tablet	1,054,916 L.L
C03DA01	ALDACTONE	B	Spironolactone - 100mg	100mg	Tablet	458,250 L.L
C03DA01	ALDACTONE	B	Spironolactone - 25mg	25mg	Tablet	237,860 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 25mg	25mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 25mg	25mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 25mg	25mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE BIOGARAN	G	Eplerenone - 25mg	25mg	Tablet, coated	1,849,127 L.L
C03DA04	HEPERONA 25	G	Eplerenone - 25mg	25mg	Tablet, coated	2,116,552 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE BIOGARAN	G	Eplerenone - 50mg	50mg	Tablet, coated	1,849,127 L.L
C03DA04	HEPERONA 50	G	Eplerenone - 50mg	50mg	Tablet, coated	2,150,148 L.L
C03DA05	KERENDIA	G	Finerenone - 10mg	10mg	Tablet, film coated	6,353,687 L.L
C03DA05	KERENDIA	G	Finerenone - 20mg	20mg	Tablet, film coated	6,353,687 L.L
C03EA01	MODURETIC	B	Hydrochlorothiazide - 50mg, Amiloride HCl - 5mg		Tablet	798,398 L.L
C04AD03	PENTOXIFYLLINE SR	G	Pentoxifylline - 1160	400mg	Tablet, sustained release	1,478,227 L.L
C04AX21	NAFTILUX	B	Naftidrofuryl oxalate acid - 200mg	200mg	Capsule	533,505 L.L
C04AX21	NAFTIPRAX	B	Naftidrofuryl hydrogen oxalate - 200mg	200mg	Tablet, film coated	614,328 L.L
C05A	ANTROLIN	B	Nifedipine - 0.3%, Lidocaine - 1.5%		Cream	1,333,092 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 500mg, Cinchocaine HCl - 500mg		Cream	290,270 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 5mg, Cinchocaine HCl - 5mg, Framycetin sulfate - 10mg, Esculoside - 10mg		Suppository	237,860 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 5mg, Lidocaine - 60mg, Zinc oxide - 400mg, Aluminium Subacetate - 50mg		Suppository	501,253 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 0.275g/100g, Lidocaine - 5g/100g, Zinc oxide - 18g/100g, Aluminium Subacetate - 3.5g/100g		Ointment	330,585 L.L
C05AE01	RECTOGESIC	G	Glyceryl trinitrate - 0.2% w/w	0.2% w/w	Ointment	2,553,301 L.L
C05AE03	DILTIGEL	G	Diltiazem HCl - 2%	2%	Gel	632,950 L.L
C05AX	HEMOCARE	G	Bismuth subgallate - 100mg, Zinc oxide - 100mg, Lidocaine - 60mg		Suppository	588,731 L.L
C05AX05	PROCTO GLYVENOL	B	Lidocaine - 40mg, Tribenoside - 400mg		Suppository	399,121 L.L
C05AX05	PROCTO GLYVENOL	B	Lidocaine HCl - 2g/100g, Tribenoside - 5g/100g		Cream	405,840 L.L
C05AX05	PILOCIN	G	Tribenoside - 5%, Lidocaine HCl - 2%		Cream	271,456 L.L

...

190